2480 — Beijing Luzhu Biotechnology Co Balance Sheet
0.000.00%
Last trade - 00:00- HK$4.60bn
- HK$3.95bn
Annual balance sheet for Beijing Luzhu Biotechnology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Cash | |||
| Short Term Investments | |||
| Cash and Short Term Investments | 564 | 582 | 608 |
| Total Inventory | |||
| Prepaid Expenses | |||
| Total Current Assets | 574 | 601 | 621 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | 142 | 292 | 488 |
| Net Intangible Assets | |||
| Long Term Investments | |||
| Other Long Term Assets | |||
| Total Assets | 726 | 1,070 | 1,167 |
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 23.4 | 94.1 | 96.3 |
| Long Term Debt | |||
| Capital Lease Obligations | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Other Liabilities | |||
| Total Liabilities | 1,310 | 133 | 146 |
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Total Equity | -585 | 937 | 1,021 |
| Total Liabilities & Shareholders' Equity | 726 | 1,070 | 1,167 |
| Total Common Shares Outstanding |